Search clinical trials for: Setipiprant

Total 11 results

Idorsia Pharmaceuticals Ltd.

Completed

Clinical Study to Explore the Efficacy of ACT-129968 in Patients With Partly Controlled Asthma (CONTROL)

Asthma

United States, Australia, Bulgaria, Germany, Hungary, Israel, Poland, Russian Federation, Serbia, Singapore, South Africa, Sweden, Ukraine
Novartis Pharmaceuticals

Terminated

Pharmacokinetics, Safety and Tolerability of Fevipiprant Delivered Via a Once Daily Chewable Tablet in Children Aged 6 to < 12 Years With Asthma

Asthma

United States
Novartis Pharmaceuticals

Completed

Pharmacokinetics of Fevipiprant (QAW039) in Patients With Hepatic Impairment Compared to Matched Healthy Subjects

Hepatic Impairment

United States
Idorsia Pharmaceuticals Ltd.

Completed

A Study to Assess the Tolerability, Safety, Pharmacodynamics, and Pharmacokinetics of Ascending Single Doses (Including Food Interaction) and Ascending Multiple Doses of ACT-453859, and Multiple Doses of Setipiprant (ACT-129968)

Healthy
Novartis Pharmaceuticals

Completed

Study of Efficacy of Fevipiprant in Patients With Nasal Polyposis and Asthma (THUNDER)

Nasal Polyps

Germany, Belgium, Italy, Argentina, Canada, Netherlands, Czechia, Poland, United States
Novartis Pharmaceuticals

Withdrawn

Mechanistic Study of Anti-inflammatory Effects of Fevipiprant in Patients With Eosinophilic Asthma.

Asthma | Eosinophilia | Asthma, Bronchial | Bronchial Asthma | Physiological Effects of Drugs
Novartis Pharmaceuticals

Terminated

Systemic Corticosteroids Avoidance Study in Severe Asthma Patients

Asthma

Germany, Belgium, South Africa, United States, Russian Federation, France, Slovakia, Spain, Thailand, Czechia, Greece, Argentina, Peru, United Kingdom, Bulgaria, Turkey, Hungary, Vietnam, Philippines, Colombia, Chile
Idorsia Pharmaceuticals Ltd.

Completed

Efficacy, Safety, and Tolerability Study of ACT-129968 in Patients With Seasonal Allergic Rhinitis (SAR)

Seasonal Allergic Rhinitis

United States
Novartis Pharmaceuticals

Completed

Pharmacokinetics and Safety of Fevipiprant in Patients With Renal Impairment Compared to Matched Healthy Subjects

Renal Insufficiency

United States, Germany
Allergan

Completed

A Safety and Efficacy Study of Setipiprant Tablets in Androgenetic Alopecia in Males

Alopecia

United States
Wahba bakhet
Elite medical center

Completed

Deep vs Moderate Neuromuscular Blockade in Day Case Laparoscopic Cholecystectomy.

Muscle Relaxation

Egypt

3

Subscribe